Living intended use
From your SOPs, last validation pack, and current admin screens, AI keeps a draft of who uses the vault and what must not change without assessment.
Services / Veeva Quality Systems
Veeva Quality SystemsCliniGene supports organizations implementing, maintaining, or improving Veeva Vault applications.
CliniGene supports organizations implementing, maintaining, or improving Veeva Vault applications.
CliniGene is an independent consulting company. References to third-party products do not imply a formal partnership unless expressly stated.
CliniGene is an independent consulting company. References to third-party products do not imply a formal partnership unless expressly stated.
A Vault that is live is not finished. Releases arrive, roles drift, tickets pile up, and the SOP no longer matches the screens. Configuration changes need assessment, verification, and an inspectable file.
CliniGene operates as independent consulting support for QualityDocs and QMS: configuration-change assessment, business verification, release readiness, periodic reviews, security, and continuing improvement. Your Vault owner still approves production changes.
Vault business owners, quality, IT, and validation leads who are implementing, maintaining, or improving Veeva QualityDocs, Veeva QMS, or related Vault quality applications.
AI supports analysis, consistency, traceability, and document preparation. Qualified professionals review every regulated deliverable, and customers retain final approval authority. AI-generated content remains a draft until it has been reviewed and approved by an authorized individual.
Questions on fit? hello@clini-gene.com or the contact form.
Each layer has a human gate. AI does not write the official quality record.
From your SOPs, last validation pack, and current admin screens, AI keeps a draft of who uses the vault and what must not change without assessment.
Vendor release notes are read against your intended-use list and configuration. Your CSA owner decides the official split.
A proposed change is drafted into impact, affected procedures, and suggested verification scenarios.
Requests are drafted into training, defect, enhancement, or access so change control stays honest.
Send the study, Vault, vendor, or inspection window. We will say what we need and what a first pass looks like.
QualityDocs, QMS, or both; who the system owner is; how access is granted; what this engagement covers.
Intended use, configuration harvest, last validation summary, and the change SOP we will follow.
Impact, affected lifecycles, workflows, quality-event processes, roles, and security.
Business verification, regression-test planning, and post-production verification under your procedure.
Release-impact draft, specialist review, documented rationale, your quality approval.
When screens and procedures diverge, we write the delta instead of pretending they match.
Who can pull the trail, what was reviewed, what remains open.
Standing admin, intake, and an inspectable ops pack if you want a managed Quality Systems arrangement.
Setting. Typical: QualityDocs or QMS already live, a configuration change or general release in the next six weeks, thin internal admin capacity.
What we do. Change or release assessment, verification plan, SOP alignment, and a file Quality can keep after we leave — or a monthly managed arrangement.
What you can show. You can show who operates the vault, what changed, how it was verified, and that CliniGene is an independent consultant — not an implied Veeva partner.
A focused configuration-change or release assessment is often one to three weeks. Onboarding a live vault to a managed rhythm is usually 4–8 weeks, then monthly or quarterly.
Email hello@clini-gene.com or use the form. Mention Veeva Quality Systems Services so we route it correctly.
Email hello@clini-gene.com or send this form. The process is already selected.
Tell us the trial, Vault, vendor, or inspection date and what “done” looks like.
Email hello@clini-gene.com if you prefer not to use the form.
Understand where AI is being used, determine potential GxP impact, identify compliance gaps, and establish a responsible implementation roadmap.
Learn more →
Establish the controls required to use AI responsibly in regulated life-sciences operations.
Learn more →
Apply risk-based CSV and CSA principles to produce clear, proportionate, and inspection-ready validation evidence.
Learn more →
Develop practical quality processes, SOPs, templates, change controls, CAPAs, training programs, and audit-readiness plans.
Learn more →
Strengthen sponsor oversight, clinical documentation, eTMF readiness, vendor management, and GCP compliance.
Learn more →
Flexible continuing support for companies that do not need a full-time Quality Systems or CSV leader.
Learn more →